Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-061805
Filing Date
2025-06-23
Accepted
2025-06-23 18:31:40
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518641-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518641-3_4seq1.xml 4 8135
  Complete submission text file 0001104659-25-061805.txt   10470
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Issuer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 750 W. JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W. JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 972-947-2871
ADAPT I Ltd. (Reporting) CIK: 0002072411 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42706 | Film No.: 251066219

Mailing Address 750 W. JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W. JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 972-947-2871
Carisome I, L.P. (Reporting) CIK: 0002072412 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42706 | Film No.: 251066218